XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Sales, net $ 11,001,102 $ 44,742,350
Cost of sales:    
Total cost of sales 8,131,574 29,174,429
Gross profit 2,869,528 15,567,921
Operating expenses:    
Sales and marketing 1,350,171 1,017,884
Research and development 129,757 95,538
General and administrative 4,130,023 4,728,481
Total operating expenses 5,609,951 5,841,903
Income (loss) from operations (2,740,423) 9,726,018
Other income - TIA 1,557,779 355,089
Unrealized gain on debt and equity securities 1,492,011 3,331,109
Gain (loss) on sale of equity securities 746,262 (38,378)
Interest and other income 209,815 73,290
Interest expense (43,555) (47,105)
Income (loss) before income taxes 1,221,889 13,400,023
Provision for income taxes 230,917 5,783,568
Net income (loss) 990,972 7,616,455
Preferred Stock dividend requirements (58,111) (58,111)
Net income (loss) applicable to common shareholders $ 932,861 $ 7,558,344
Basic earnings per share $ 0.03 $ 0.23
Diluted earnings per share $ 0.03 $ 0.23
Weighted average common shares outstanding:    
Basic (in shares) 29,937,159 33,265,453
Diluted (in shares) 29,963,763 33,594,142
Costs of manufactured product    
Cost of sales:    
Total cost of sales $ 7,361,865 $ 26,606,238
Royalty expense to shareholder    
Cost of sales:    
Total cost of sales $ 769,709 $ 2,568,191